Effect of measles mumps rubella vaccine in treatment of common warts
Background: There are many destructive and immunotherapeutic options available for the treatment of common warts, but no treatment is 100% effective and usually cause pain and scarring.
Anuja A. Dhope, Bhushan Madke, A. Singh
semanticscholar +1 more source
Background Since January 2016, a resurgence of measles in Romania has led to the third measles epidemic in the past 12 years; 64 deaths have been confirmed so far–the highest number of measles-related deaths since the measles-mumps-rubella (MMR) vaccine ...
M. Lazăr+3 more
semanticscholar +1 more source
Mumps Antibody Response in Young Adults After a Third Dose of Measles-Mumps-Rubella Vaccine
Baseline mumps antibody titers were high-seropositive for 93.4% of subjects, low-seropositive for 5.8%, and seronegative for
A. Fiebelkorn+8 more
semanticscholar +1 more source
School-based educational and on-site vaccination intervention among adolescents: study protocol of a cluster randomised controlled trial [PDF]
INTRODUCTION: Childhood vaccination programmes have been established in all Organisation for Economic Co-operation and Development (OECD) countries; however, measles, mumps and rubella (MMR) as well as diphtheria, tetanus, pertussis and polio (Tdap-IPV ...
Bethke, Norma+2 more
core +1 more source
Background and objectives: Plane wart treatment is challenging; modalities such as cauterization and cryotherapy having a great probability to recur, as well as the risk of scarring, discomfort, and expensive costs.
Banu Muhammed Jaza Noori+1 more
doaj +1 more source
The mumps surveillance data from 2004 to 2011 showed that the incidence of mumps remained high after the one-dose measles-mumps-rubella (MMR) vaccine was introduced in China in 2008.
Yuanbao Liu+8 more
semanticscholar +1 more source
Parents' champions vs. vested interests: who do parents believe about MMR? A qualitative study. [PDF]
BACKGROUND: Despite the Government acting quickly to reassure parents about MMR safety following the publication of the 1998 paper by Wakefield and colleagues, MMR uptake declined.
Hilton, Shona+2 more
core +2 more sources
Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients
The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against coronavirus disease 2019 (COVID-19). Our aim was to determine whether any MMR IgG titers are inversely correlated with severity in recovered COVID-19 patients ...
Jeffrey E. Gold+9 more
doaj +1 more source
A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children [PDF]
Objectives: A multicenter, single-blind, randomized, controlled clinical study was conducted in healthy 15–18-month-old children in order to assess the immunogenicity and reactogenicity of three consecutive lots of a new measles-mumps-rubella (MMR ...
Bock, Hans L.+5 more
core +1 more source
Shots at school? Public attitudes about vaccination services in school‐based health centers
Abstract Vaccination rates have dropped across the United States. Vaccination hesitancy plays a major role in this development, but access barriers are also a contributing factor. Access barriers are particularly prevalent among marginalized populations.
Simon F. Haeder
wiley +1 more source